Atlas Trials

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Clinical trial NCT02385019 · UNKNOWN

Trial details

NCT number
NCT02385019
Sponsor
Instituto de Medicina Molecular João Lobo Antunes
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Graft vs Host Disease
Start date
2015-03-01
Primary completion
2019-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.